Tag: glioblastoma treatment

brain cancer


Ivy Brain Tumor Center and SonALAsense Announce Positive Initial Results

The Ivy Brain Tumor Center at Barrow Neurological Institute and SonALAsense announced positive results in their first-in-human Phase 0/1 clinical trial of SDT in recurrent glioblastoma patients. The initial results were presented at the European Society for Medical Oncology Congress today by Nader Sanai, MD, Director of the Ivy Brain Tumor Center. “The Ivy Center’s Phase 0/1 study has shown a promising translation of the preclinical results of SDT in patients with glioblastoma.

Read More